Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO
Chalk River, Ontario, January 16, 2025 – Actineer, a joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., today announced the appointment of Joseph Oliverio as President and Chief Executive Officer. With extensive industry leadership experience, Mr. Oliverio is poised to drive Actineer’s global expansion in Actinium-225 (Ac-225) production.
January 16, 2025